Back to Journals » OncoTargets and Therapy » Volume 11

Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA

Total article views   Abstract views HTML views PDF downloads Totals
5,770 Dovepress* 3,639 1,290+ 1,192 4,929
PubMed Central* 0 841 222 841
Totals 3,639 2,131 1,414 5,770
*Since 22 December 2017
+Since July 2016

View citations on PubMed Central and Google Scholar